Schwab US Dividend Equity ETF Reverses In December: What's Going On?
Smart Money Is Betting Big In XOM Options
2024's 'Biggest Loses' That Could See Reversal in 2025
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
Deal Dispatch: Honeywell, Textron And Soho House Are Making M&A Moves
Options Market Statistics: Tesla's Rollercoaster Week Ends with Friday Sell-Off; Options Pop
Catalyst Watch: Labor Pains for Amazon & Starbucks, Nasdaq Call-up for MicroStrategy and Pony AI Ratings
Defensive Oil Stocks To Watch In 2025 Amid $70 Brent Forecast: JP Morgan
Merck Downgraded by BMO Over Keytruda Concerns
RxSight Cut to Hold at Stifel on Competition Concerns
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
Coca-Cola Fizz Fades As Stock Charts A Death Cross – Can Australian Spirits Bring Cheer?
Dividend Roundup: Mastercard, Broadcom, Southwest Airlines, Waste Management, and More
Merck & Co Analyst Ratings
Energy Transfer Enters 20-year LNG Sale And Purchase Agreement With Chevron Related To Its Lake Charles LNG Project
Lumen Wireline Assets May Be Worth $7B-$10B in a Sale - Analyst
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
Spotlight on Chevron: Analyzing the Surge in Options Activity